Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today.
Revenues increased 12% year-over-year to $11.7 billion.
On a GAAP basis, the company reported a net income of $594 million, or $0.10 per share, compared to a loss of $337 million, or $0.06 per share, last year.
Adjusted net income increased 15% to $2.3 billion while adjusted EPS rose 14% to $0.42.
For the full year of 2021, revenues are expected to be $59.4-61.4 billion while adjusted EPS guidance was raised to a range of $3.10-3.20 from the previous range of $3.00-3.10.
Prior performance
